Construction and validation of a novel apoptosis-associated prognostic signature related to osteosarcoma metastasis and immune infiltration

• Published in: Translational oncology 2022-08, Vol.22, p.101452-101452, Article 101452
• Main Authors: Fu, Yucheng, Jin, Zhijian, Shen, Yuhui, Zhang, Zhusheng, Li, Meng, Liu, Zhuochao, He, Guoyu, Wu, Jintao, Wen, Junxiang, Bao, Qiyuan, Wang, Jun, Zhang, Weibin
• Format: Article
• Language: English
• Subjects: Apoptosis; Immune; Metastasis; Original Research; Osteosarcoma; Prognosis
• ISSN: 1936-5233; 1936-5233
• DOI: 10.1016/j.tranon.2022.101452

•Osteosarcoma is one of the most aggressive diseases which often develops metastasis.•Apoptosis relates to the recurrence and metastasis of osteosarcoma and the related signature could predict the prognosis of patients.•A novel apoptosis-associated prognosis signature related to osteosarcoma metastasis and immune infiltration has been developed.•The signature could help to predict the prognosis of osteosarcoma patients and serve as the potential targets for anti-cancer treatment. Apoptosis played vital roles in the formation and progression of osteosarcoma. However, no studies elucidated the prognostic relationships between apoptosis-associated genes (AAGs) and osteosarcoma. The differentially expressed genes associated with osteosarcoma metastasis and apoptosis were identified from GEO and MSigDB databases. The apoptosis-associated prognostic signature was established through univariate and multivariate cox regression analyses. The Kaplan–Meier (KM) survival curve, ROC curve and nomogram were constructed to investigate the predictive value of this signature. CIBERSORT algorithm and ssGSEA were used to explore the relationships between immune infiltration and AAG signature. The above results were validated in another GEO dataset and the expression of AAGs was also validated in osteosarcoma patient samples by immunohistochemistry. HSPB1 and IER3 were involved in AAG signature. In training and validation datasets, apoptosis-associated risk scores were negatively related to patient survival rates and the AAG signature was regarded as the independent prognostic factor. ROC and calibration curves demonstrated the signature and nomogram were reliable. GSEA revealed the signature related to immune-associated pathways. ssGSEA indicated that one immune cell and three immune functions were significantly dysregulated. The immunohistochemistry analyses of patients’ samples revealed that AAGs were significantly differently expressed between metastasis and non-metastasis osteosarcomas. The present study identified and validated a novel apoptosis-associated prognostic signature related to osteosarcoma metastasis. It could serve as the potential biomarker and therapeutic targets for osteosarcoma in the future.